Regeneron halts antibody trial in seriously ill Covid patients
Drug hailed as coronavirus ‘cure’ by Donald Trump will still be studied in mild-to-moderate cases
Full Article
Regeneron halts antibody trial in seriously ill Covid patients
FT.com
0 shares
1 views
You might like
Related news coverage
Regeneron COVID-19 drug trial halted in sickest patients
Upworthy
pended testing of its Covid-19 antibody drug in the sickest hospitalized patients because of a safety concern, the latest setback..
-
Regeneron halts trial of COVID-19 antibody drug in sickest hospitalized patients
Upworthy
-
2nd study testing a COVID-19 antibody drug has a setback
SeattlePI.com
-
Trial of Regeneron’s Covid-19 Antibody Drug Is Halted in Sickest Hospital Patients
Upworthy
-
Regeneron to exclude severely/critically ill COVID-19 patients from antibody cocktail study
SeekingAlpha
Advertisement
More coverage
Can You Get The 'Antibody Cocktail' The President Got For COVID?
Newsy
Watch VideoMonoclonal antibodies or “antibody cocktails” are getting a lot of attention as the next promising treatment in the..
Eli Lilly wins US$375mln US government order for COVID-19 drug
Proactive Investors